BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38707641)

  • 1. Ginsenosides for the treatment of insulin resistance and diabetes: Therapeutic perspectives and mechanistic insights.
    Kim TH
    J Ginseng Res; 2024 May; 48(3):276-285. PubMed ID: 38707641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginseng for the treatment of diabetes and diabetes-related cardiovascular complications: a discussion of the evidence
    Karmazyn M; Gan XT
    Can J Physiol Pharmacol; 2019 Apr; 97(4):265-276. PubMed ID: 30395481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenosides attenuate methylglyoxal-induced impairment of insulin signaling and subsequent apoptosis in primary astrocytes.
    Chu JM; Lee DK; Wong DP; Wong RN; Yung KK; Cheng CH; Yue KK
    Neuropharmacology; 2014 Oct; 85():215-23. PubMed ID: 24878245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
    Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes.
    Bai L; Gao J; Wei F; Zhao J; Wang D; Wei J
    Front Pharmacol; 2018; 9():423. PubMed ID: 29765322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the pyroptosis-associated inflammasome pathway: The important potential mechanism of ginsenosides in ameliorating diabetes and its complications.
    Liu P; Zhang Z; Cai Y; Yang Y; Yuan J; Chen Q
    Eur J Med Chem; 2023 May; 253():115336. PubMed ID: 37031528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of mitophagy in diabetes mellitus and its complications and traditional Chinese medicine intervention: a review].
    Fan LH; Yang X; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):46-54. PubMed ID: 38403337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of natural products used in the treatment of diabetes mellitus.
    Prabhakar PK; Doble M
    Chin J Integr Med; 2011 Aug; 17(8):563-74. PubMed ID: 21826590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment.
    Meng X; Liu X; Tan J; Sheng Q; Zhang D; Li B; Zhang J; Zhang F; Chen H; Cui T; Li M; Zhang S
    Chin Med; 2023 Jun; 18(1):75. PubMed ID: 37349778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological potential of ginseng and its major component ginsenosides.
    Ratan ZA; Haidere MF; Hong YH; Park SH; Lee JO; Lee J; Cho JY
    J Ginseng Res; 2021 Mar; 45(2):199-210. PubMed ID: 33841000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenosides in cancer: A focus on the regulation of cell metabolism.
    Yao W; Guan Y
    Biomed Pharmacother; 2022 Dec; 156():113756. PubMed ID: 36228372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin.
    Liu Z; Li W; Li X; Zhang M; Chen L; Zheng YN; Sun GZ; Ruan CC
    J Ethnopharmacol; 2013 Jan; 145(1):233-40. PubMed ID: 23147499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and medical applications of
    Kim JH
    J Ginseng Res; 2018 Jul; 42(3):264-269. PubMed ID: 29983607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Co-administration of intranasally delivered insulin and proinsulin C-peptide to rats with the types 1 and 2 diabetes mellitus restores their metabolic parameters.].
    Derkach KV; Bondareva VM; Shpakov AO
    Adv Gerontol; 2017; 30(6):851-858. PubMed ID: 29608829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Studies of Natural Products Targeting the Gut Microbiota: Beneficial Effects on Diabetes.
    Jiang X; Sun B; Zhou Z
    J Agric Food Chem; 2022 Jul; 70(28):8569-8581. PubMed ID: 35816090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanism of active components from ginseng to manage diabetes mellitus based on network pharmacology and molecular docking.
    Li MH; Jin MH; Hu RY; Tang S; Li KK; Gong XJ; Sun YS; Wang YP; Wang Z; Li W
    Sci Rep; 2023 Jan; 13(1):793. PubMed ID: 36646777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Therapeutic Agents for Management of Diabetes Mellitus: A Hope for Drug Designing against Diabetes Mellitus.
    Elkhalifa AME; Nazar M; Ali SI; Khursheed I; Taifa S; Ahmad Mir M; Shah IH; Malik M; Ramzan Z; Ahad S; Bashir N; Elamin E; Bazie EA; Ahmed EM; Alruwaili MM; Baltoyour AW; Alarfaj AS; Ali Al Bataj I; Arabe AMA; Nabi SU
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255714
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.